Is XRAY undervalued or overvalued?

As of 2025-03-27, the Intrinsic Value of DENTSPLY SIRONA Inc (XRAY) is (115.70) USD. This XRAY valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 15.57 USD, the upside of DENTSPLY SIRONA Inc is -843.10%. This means that XRAY is overvalued by 843.10%.

The range of the Intrinsic Value is (836.10) - (68.80) USD

Note: result may not be accurate due to the invalid valuation result of DCF model.

	Range	Selected	Upside
a
DCF (Growth 5y)	(836.10) - (68.80)	(115.70)	-843.1%
DCF (Growth 10y)	(60.33) - (634.27)	(95.65)	-714.3%
DCF (EBITDA 5y)	(30.74) - (37.49)	(1,234.50)	-123450.0%
DCF (EBITDA 10y)	(29.84) - (36.47)	(1,234.50)	-123450.0%
Fair Value	-22.39 - -22.39	-22.39	-243.81%
P/E	(54.33) - (81.49)	(67.91)	-536.2%
EV/EBITDA	42.21 - 54.68	47.63	205.9%
EPV	21.63 - 34.45	28.04	80.1%
DDM - Stable	(68.45) - (305.78)	(187.11)	-1301.8%
DDM - Multi	(38.96) - (136.73)	(60.81)	-490.5%